Addus HomeCare Co. (NASDAQ:ADUS) Receives $132.78 Average PT from Analysts

Shares of Addus HomeCare Co. (NASDAQ:ADUS) have been given a consensus recommendation of “Buy” by the ten research firms that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, seven have given a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $132.78.

Several equities research analysts have issued reports on the stock. JMP Securities assumed coverage on shares of Addus HomeCare in a report on Monday, December 16th. They issued an “outperform” rating and a $150.00 price target on the stock. Stephens reissued an “overweight” rating and issued a $142.00 price target on shares of Addus HomeCare in a report on Wednesday, March 12th. StockNews.com lowered shares of Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Finally, Oppenheimer boosted their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research note on Friday, January 24th.

Addus HomeCare Trading Up 0.3 %

Shares of ADUS stock opened at $91.24 on Monday. Addus HomeCare has a 1 year low of $87.88 and a 1 year high of $136.72. The firm’s fifty day simple moving average is $113.25 and its 200 day simple moving average is $122.39. The firm has a market capitalization of $1.66 billion, a P/E ratio of 20.88, a price-to-earnings-growth ratio of 1.41 and a beta of 0.97.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.35 by ($0.09). The business had revenue of $297.14 million during the quarter, compared to the consensus estimate of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Equities research analysts anticipate that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the transaction, the chief executive officer now owns 79,397 shares in the company, valued at $9,905,569.72. This represents a 23.95 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 4.60% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in ADUS. Assetmark Inc. lifted its position in Addus HomeCare by 11.5% during the 3rd quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock worth $156,000 after buying an additional 121 shares in the last quarter. Crossmark Global Holdings Inc. acquired a new position in Addus HomeCare during the 3rd quarter worth about $228,000. Entropy Technologies LP acquired a new position in Addus HomeCare during the 3rd quarter worth about $226,000. Victory Capital Management Inc. lifted its position in Addus HomeCare by 6.1% during the 3rd quarter. Victory Capital Management Inc. now owns 84,960 shares of the company’s stock valued at $11,302,000 after purchasing an additional 4,913 shares during the period. Finally, Royce & Associates LP boosted its stake in shares of Addus HomeCare by 1.2% in the 3rd quarter. Royce & Associates LP now owns 8,924 shares of the company’s stock valued at $1,187,000 after purchasing an additional 109 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.